Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Oermann

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Vaccine|May 15, 2003
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosisPedro A Piedra, Stanley G Cron, Alan Jewell, et al.
Pediatric Pulmonology|November 24, 2006
Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosisDaniel F Garcia, Peter W Hiatt, Alan Jewell, et al.
Pediatric Pulmonology|February 11, 2010
Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosisMarci K Sontag, Alexandra L Quittner, Avani C Modi, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 6, 2014
Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE studyH A W M Tiddens, K De Boeck, J P Clancy, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 19, 2012
Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trialBaroukh M Assael, Tacjana Pressler, Diana Bilton, et al.
Pediatric Pulmonology|December 10, 2020
Innovating and adapting in pediatric pulmonology and sleep medicine during the COVID-19 pandemic: ATS pediatric assembly web committee consensus statement for initial COVID-19 virtual responseJane B Taylor, Christopher M Oermann, Robin R Deterding, et al.
Annals of the American Thoracic Society|December 31, 2014
Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infectionPeter J Mogayzel, Edward T Naureckas, Karen A Robinson, et al.
Pancreas|April 22, 2006
Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patientsDrucy Borowitz, Christopher H Goss, Christopher Stevens, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 27, 2023
Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosisKimberly G Stephenson, Abby J Lingle, Kelly A Baumberger, et al.
Annals of the American Thoracic Society|June 14, 2016
ATS Core Curriculum 2016: Part III. Pediatric Pulmonary MedicineDebra Boyer, Carey C Thomson, Robyn Cohen, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Vaccine|May 15, 2003
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosisPedro A Piedra, Stanley G Cron, Alan Jewell, et al.
Pediatric Pulmonology|November 24, 2006
Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosisDaniel F Garcia, Peter W Hiatt, Alan Jewell, et al.
Pediatric Pulmonology|February 11, 2010
Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosisMarci K Sontag, Alexandra L Quittner, Avani C Modi, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 6, 2014
Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE studyH A W M Tiddens, K De Boeck, J P Clancy, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 19, 2012
Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trialBaroukh M Assael, Tacjana Pressler, Diana Bilton, et al.
Pediatric Pulmonology|December 10, 2020
Innovating and adapting in pediatric pulmonology and sleep medicine during the COVID-19 pandemic: ATS pediatric assembly web committee consensus statement for initial COVID-19 virtual responseJane B Taylor, Christopher M Oermann, Robin R Deterding, et al.
Annals of the American Thoracic Society|December 31, 2014
Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infectionPeter J Mogayzel, Edward T Naureckas, Karen A Robinson, et al.
Pancreas|April 22, 2006
Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patientsDrucy Borowitz, Christopher H Goss, Christopher Stevens, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 27, 2023
Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosisKimberly G Stephenson, Abby J Lingle, Kelly A Baumberger, et al.
Annals of the American Thoracic Society|June 14, 2016
ATS Core Curriculum 2016: Part III. Pediatric Pulmonary MedicineDebra Boyer, Carey C Thomson, Robyn Cohen, et al.
Pageof 7